|Articles|April 1, 2001
- Pharmaceutical Executive-04-01-2001
- Volume 0
- Issue 0
Regulation: Two-Track Plan
Author(s)Kevin Gopal
Brussels-Two types of mutual recognition procedures are necessary to ensure that generics get to market as quickly as possible, according to the European Generics Medicines Association.
Advertisement
Articles in this issue
over 25 years ago
Internet DTC - Minding Your P's & Q'sover 25 years ago
Policy: Tectonic Shiftover 25 years ago
Liberated?over 25 years ago
A Matter of Tasteover 25 years ago
Partnerships: Bargaining Biotechsover 25 years ago
Pediatric Mandateover 25 years ago
Genentech's Passion for Patientsover 25 years ago
Regulation: OK After AllAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5